Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consens

KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it

Kala Bio (NASDAQ:KALA) reported quarterly earnings of $0.86 per share which beat the analyst consens

Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen I

Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a

U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma

U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma

US stocks mixed, Dow down 300 points. Dow down 0.71%, Nasdaq up 0.21%, S&P 500 down 0.13%. Energ

US stocks traded mixed, with Dow down 0.63% while NASDAQ and S&P 500 rose. Energy shares rose by

Indaptus Therapeutics surged 64.65% in after-hours trading following a major insider investment and

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on M

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monda

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling brea

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders look

  On Wednesday, 152 stocks made new 52-week lows.

  On Tuesday, 298 companies achieved new lows for the year.

  On Thursday, 241 companies hit new 52-week lows.

  Tuesday's session saw 167 companies set new 52-week lows.

  Friday's session saw 236 companies set new 52-week lows.

  During Monday's session, 96 stocks hit new 52-week lows.